Lipopolysaccharide preconditioning facilitates M2 activation of resident microglia after spinal cord injury

Journal of Neuroscience Research

Volumn 92, Issue 12, 2014, Pages 1647-1658

  Hayakawa, Kentaro ^a,b   Okazaki, Rentaro ^a,b   Morioka, Kazuhito ^a   Nakamura, Kozo ^b   Tanaka, Sakae ^b   Ogata, Toru ^a  

^a NATIONAL REHABILITATION CENTER FOR PERSONS WITH DISABILITIES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endotoxin; Inflammation; Microglial activation

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; CYTOKINE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDE PRECONDITIONING; MACROPHAGE; MACROPHAGE ACTIVATION; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL CORD INJURY; TISSUE REPAIR; TRANSCRIPTION INITIATION; VASCULARIZATION; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COMPLICATION; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; GENETICS; METABOLISM; MOVEMENT DISORDERS; PATHOLOGY; SPINAL CORD INJURIES;

ANIMALS; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MICROGLIA; MOVEMENT DISORDERS; NERVE TISSUE PROTEINS; SPINAL CORD INJURIES;

EID: 84911987395     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23448     Document Type: Article

References (47)

1. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. 2006. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23:635-659.
2. Bell MT, Puskas F, Agoston VA, Cleveland JC Jr, Freeman KA, Gamboni F, Herson PS, Meng X, Smith PD, Weyant MJ, Fullerton DA, Reece TB. 2013. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation 128:S152-S156.
3. Bethea JR, Dietrich WD. 2002. Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 15:355-360.
4. Biswas SK, Lopez-Collazo E. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30:475-487.
5. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V. 2007. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 179:4083-4092.
6. Brewer KL, Bethea JR, Yezierski RP. 1999. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol 159:484-493.
7. Chen KB, Uchida K, Nakajima H, Yayama T, Hirai T, Rodriguez Guerrero A, Kobayashi S, Ma WY, Liu SY, Zhu P, Baba H. 2011. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats. Spine 36:2122-2129.
8. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohlman SA, Trapp BD. 2012. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 32:11706-11715.
9. Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, Apte RS. 2009. Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy. PloS One 4:e7121.
10. David S, Kroner A. 2011. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388-399.
11. Dirnagl U, Becker K, Meisel A. 2009. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412.
12. Fan H, Cook JA. 2004. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10:71-84.
13. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC. 2006. The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269.
14. Honda K, Taniguchi T. 2006. IRFs: master regulators of signaling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644-658.
15. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. 2014. Anti-inflammatory M2, but not proinflammatory M1, macrophages promote angiogenesis in vivo. Angiogenesis 17:109-118.
16. Kamei N, Kwon SM, Kawamoto A, Ii M, Ishikawa M, Ochi M, Asahara T. 2012. Contribution of bone marrow-derived endothelial progenitor cells to neovascularization and astrogliosis following spinal cord injury. J Neurosci Res 90:2281-2292.
17. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG. 2007. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 102:37-50.
18. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
19. Kim HM, Hwang DH, Lee JE, Kim SU, Kim BG. 2009. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PloS One 4:e4987.
20. Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S. 1997. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197:478-493.
21. Lastres-Becker I, Cartmell T, Molina-Holgado F. 2006. Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J Neuroimmunol 173:108-116.
22. Leow-Dyke S, Allen C, Denes A, Nilsson O, Maysami S, Bowie AG, Rothwell NJ, Pinteaux E. 2012. Neuronal Toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflamm 9:230.
23. Li WC, Jiang DM, Hu N, Qi XT, Qiao B, Luo XJ. 2013. Lipopolysaccharide preconditioning attenuates neuroapoptosis and improves functional recovery through activation of Nrf2 in traumatic spinal cord injury rats. Int J Neurosci 123:240-247.
24. Lin HY, Huang CC, Chang KF. 2009. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. Pediatr Res 66:254-259.
25. Longhi L, Gesuete R, Perego C, Ortolano F, Sacchi N, Villa P, Stocchetti N, De Simoni MG. 2011. Long-lasting protection in brain trauma by endotoxin preconditioning. J Cereb Blood Flow Metab 31:1919-1929.
26. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555.
27. Mockford KA, Girn HR, Homer-Vanniasinkam S. 2009. Postconditioning: current controversies and clinical implications. Eur J Vasc Endovasc Surg 37:437-442.
28. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
29. Nikodemova M, Small AL, Smith SM, Mitchell GS, Watters JJ. 2013. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats. Neurobiol Dis 69:43-53.
30. Nishimura S, Yasuda A, Iwai H, Takano M, Kobayashi Y, Nori S, Tsuji O, Fujiyoshi K, Ebise H, Toyama Y, Okano H, Nakamura M. 2013. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Mol Brain 6:3.
31. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834.
32. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 61:623-633.
33. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, Sica A. 2009. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106:14978-14983.
34. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4:814-821.
35. Rolls A, Shechter R, Schwartz M. 2009. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10:235-241.
36. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. 2004. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35:2576-2581.
37. Samanta M, Iwakiri D, Takada K. 2008. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27:4150-4160.
38. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, Temple S. 2004. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338-1340.
39. Singh AK, Jiang Y. 2004. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201:197-207.
40. Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, Stenzel-Poore MP. 2011. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosc i31:8456-8463.
41. Stirling DP, Yong VW. 2008. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 86:1944-1958.
42. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM. 1997. Lipopolysaccharide pretreatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267-270.
43. Thompson CD, Zurko JC, Hanna BF, Hellenbrand DJ, Hanna A. 2013. The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma 30:1311-1324.
44. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994-1000.
45. Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP. 2011. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflamm 8:140.
46. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643.
47. Zhang YK, Liu JT, Peng ZW, Fan H, Yao AH, Cheng P, Liu L, Ju G, Kuang F. 2013. Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury. J Neuroinflamm 10:112.